Connie Kasari is professor of human development and psychology at the University of California, Los Angeles. She is the principal investigator for several multi-site research programs and a founding member of the university’s Center for Autism Research and Treatment.
Connie Kasari
From this contributor
How much behavioral therapy does an autistic child need?
People tend to believe that, regardless of the treatment, more is always better. But is it?
How much behavioral therapy does an autistic child need?
By
Connie Kasari
27 August 2019 | 6 min read
Learning when to treat repetitive behaviors in autism
Some restricted and repetitive behaviors may have hidden benefits for people with autism, so scientists should work to find a happy medium between acceptance and change.
Learning when to treat repetitive behaviors in autism
By
Clare Harrop, Connie Kasari
10 November 2015 | 8 min read
School’s in
School-based interventions are arguably the best way to reach the truly underserved, under-represented and under-resourced children with autism, says Connie Kasari.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read